Status:
COMPLETED
Assessing Response to Albuterol in Bronchiolitis
Lead Sponsor:
Connecticut Children's Medical Center
Conditions:
Bronchiolitis
Eligibility:
All Genders
Up to 2 years
Brief Summary
Bronchiolitis is a significant cause of morbidity and hospitalizations in children, accounting for more than 125,000 hospitalized children per year in the United States. Although treatment is largely ...
Detailed Description
We propose to conduct a prospective observational study of healthcare providers to determine the accuracy of clinical assessment as compared to the assessment of pulmonary mechanics in a population of...
Eligibility Criteria
Inclusion
- Hospitalization with a primary admission diagnosis of bronchiolitis
- Age between birth and 2 years
- Intubated with \< 1 cm H2O leak around endotracheal tube
- Receiving inhaled albuterol therapy
Exclusion
- \- Not meeting inclusion criteria
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2016
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT01238445
Start Date
November 1 2010
End Date
November 1 2016
Last Update
February 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Connecticut Children's Medical Center
Hartford, Connecticut, United States, 06106